This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
- WBC =
- white blood (cell) count •
- RBC/hpf =
- red blood cells per high-power field
Purpura fulminans is an acute, rapidly progressive hemorrhagic necrosis of the skin attributable to dermal vascular necrosis that is associated with disseminated intravascular coagulation. It is a rare and occasionally life-threatening disorder that occurs most commonly in the setting of acute, severe bacterial or viral infection, or as a postinfectious syndrome after infections such as primary varicella or scarlet fever.1–4Postinfectious purpura fulminans usually occurs 7 to 10 days after onset of symptoms of the acute infection.5 The ecchymotic lesions are most commonly distributed symmetrically on the lower extremities and buttocks, although the trunk and upper extremities can be involved. Visceral involvement is less frequent but can lead to hematuria or gastrointestinal hemorrhage.6
Transient or congenital deficiencies of protein C or protein S have been documented in many cases of purpura fulminans in recent years.1 ,4 ,7 ,8 Protein C is the best known among the identified anticoagulant factors in the delicate molecular balance of hemostasis. Activated protein C degrades activated coagulation factors VIIIa and Va, attenuating their procoagulant activation of factors X and prothrombin. Protein S is a cofactor to activated protein C, which accounts for the increased risk of thrombosis associated with protein S deficiency states.9
Factor V Leiden, a factor V variant resulting from a single point mutation at nucleotide 1691 (guanine to adenine, resulting in arginine 506 to glutamine), has been recognized recently as a risk factor for thrombotic events in adults.10 Reported thromboses in children with factor V Leiden have included catheter-related thrombosis11 and renal vein and venous sinus thrombosis in a neonate.12 The presence of factor V Leiden also heightens the risk for thrombotic events among adolescents and young women who use oral contraceptives (odds ratio, 4.9; 95% confidence interval, 2.0–11.7).13
The factor V Leiden …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.